(Q33406936)

English

Phase II study of bevacizumab and temsirolimus combination therapy for recurrent glioblastoma multiforme

scientific article

Statements

Phase II study of bevacizumab and temsirolimus combination therapy for recurrent glioblastoma multiforme (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit